148 related articles for article (PubMed ID: 38106742)
1. Oral Pemphigus Vulgaris: A Case Report With Review of Literature.
Albagieh H; Alhamid RF; Alharbi AS
Cureus; 2023 Nov; 15(11):e48839. PubMed ID: 38106742
[TBL] [Abstract][Full Text] [Related]
2. Erythema multiforme-like lip presentation in pemphigus vulgaris patients: a multicenter case series.
Subahi G; Waheeb S; Binmadi N; Almazrooa S; Akeel S; Öhman J; Dafar A
BMC Oral Health; 2023 Dec; 23(1):952. PubMed ID: 38041037
[TBL] [Abstract][Full Text] [Related]
3. Correlation of desmoglein 1 and 3 immunohistochemistry with autoantibody levels and clinical severity in pemphigus.
Pradeep A; Eapen M; Jagadeeshan S; Kani K
J Cutan Pathol; 2023 Dec; 50(12):1104-1109. PubMed ID: 37584110
[TBL] [Abstract][Full Text] [Related]
4. Influence of intravenous immunoglobulin therapy on autoantibody titers to desmoglein 3 and desmoglein 1 in pemphigus vulgaris.
Sami N; Bhol KC; Ahmed RA
Eur J Dermatol; 2003; 13(4):377-81. PubMed ID: 12948919
[TBL] [Abstract][Full Text] [Related]
5. Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels.
Terada A; Akasaka E; Nakano H; Sawamura D
J Dermatol; 2023 Nov; 50(11):1501-1505. PubMed ID: 37485682
[TBL] [Abstract][Full Text] [Related]
6. Oral Pemphigus Vulgaris.
Subadra K; S S; Warrier S A
Cureus; 2021 Sep; 13(9):e18005. PubMed ID: 34671517
[TBL] [Abstract][Full Text] [Related]
7. Pemphigus vulgaris: a case report.
Thanmai JV; Ramlal G; Tejaswi K; Mounica IL
Pan Afr Med J; 2022; 42():184. PubMed ID: 36212921
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous pemphigus vulgaris with skin features similar to the classic mucocutaneous type: a case report and review of the literature.
Shinkuma S; Nishie W; Shibaki A; Sawamura D; Ito K; Tsuji-Abe Y; Natsuga K; Chan PT; Amagai M; Shimizu H
Clin Exp Dermatol; 2008 Nov; 33(6):724-8. PubMed ID: 18627395
[TBL] [Abstract][Full Text] [Related]
9. Disease progression from mucosal to mucocutaneous involvement in a patient with desquamative gingivitis associated with pemphigus vulgaris.
Endo H; Rees TD; Hallmon WW; Kuyama K; Nakadai M; Kato T; Kono Y; Yamamoto H
J Periodontol; 2008 Feb; 79(2):369-75. PubMed ID: 18251653
[TBL] [Abstract][Full Text] [Related]
10. Neonatal pemphigus vulgaris with extensive mucocutaneous lesions from a mother with oral pemphigus vulgaris.
Campo-Voegeli A; Muñiz F; Mascaró JM; García F; Casals M; Arimany JL; Amagai M; Camps A
Br J Dermatol; 2002 Oct; 147(4):801-5. PubMed ID: 12366435
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris.
Mimouni D; Blank M; Payne AS; Anhalt GJ; Avivi C; Barshack I; David M; Shoenfeld Y
Clin Exp Immunol; 2010 Dec; 162(3):543-9. PubMed ID: 20964642
[TBL] [Abstract][Full Text] [Related]
12. Novel ELISA systems for antibodies to desmoglein 1 and 3: correlation of disease activity with serum autoantibody levels in individual pemphigus patients.
Schmidt E; Dähnrich C; Rosemann A; Probst C; Komorowski L; Saschenbrecker S; Schlumberger W; Stöcker W; Hashimoto T; Bröcker EB; Recke A; Rose C; Zillikens D
Exp Dermatol; 2010 May; 19(5):458-63. PubMed ID: 20163452
[TBL] [Abstract][Full Text] [Related]
13. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis.
Femiano F
Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959
[TBL] [Abstract][Full Text] [Related]
14. Acantholysis may precede elevation of circulating anti-desmoglein 3 antibody levels in pemphigus vulgaris presenting with desquamative gingivitis.
Endo H; Rees TD; Niwa H; Kuyama K; Oshima M; Serizawa T; Tanaka S; Komiya M; Ito T
Clin Exp Dent Res; 2019 Jun; 5(3):219-224. PubMed ID: 31249702
[TBL] [Abstract][Full Text] [Related]
15. Ca
Schmitt T; Egu DT; Walter E; Sigmund AM; Eichkorn R; Yazdi A; Schmidt E; Sárdy M; Eming R; Goebeler M; Waschke J
Br J Dermatol; 2021 Sep; 185(3):595-604. PubMed ID: 33792909
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
17. Pemphigus vulgaris in a neonate born to a mother with pemphigus vulgaris: A case report.
Anand A; Awake P; Bhosale A; Bindu R; Kher A; Bhanap P
Clin Case Rep; 2023 Dec; 11(12):e8343. PubMed ID: 38116514
[TBL] [Abstract][Full Text] [Related]
18. The involvement of ADAM10 in acantholysis in mucocutaneous pemphigus vulgaris depends on the autoantibody profile of each patient.
Ivars M; España A; Alzuguren P; Pelacho B; Lasarte JJ; López-Zabalza MJ
Br J Dermatol; 2020 May; 182(5):1194-1204. PubMed ID: 31370093
[TBL] [Abstract][Full Text] [Related]
19. Pemphigus vulgaris with circulating anti-desmoglein 3 and anti-BP180 antibodies: a case report and brief review of cases with coexistence of pemphigus vulgaris and bullous pemphigoid.
Cassano N; Mastrandrea V; Tampoia M; Filotico R; Vestita M; Vena GA
J Biol Regul Homeost Agents; 2009; 23(3):197-201. PubMed ID: 19828097
[TBL] [Abstract][Full Text] [Related]
20. Response of ocular pemphigus vulgaris to therapy. Case report and review of literature.
Olszewska M; Komor M; Mazur M; Rogozinski T
J Dermatol Case Rep; 2008 Mar; 2(1):1-3. PubMed ID: 21886701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
